SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001509190-19-000027
Filing Date
2019-04-19
Accepted
2019-04-19 16:11:21
Documents
9
Period of Report
2019-04-19
Effectiveness Date
2019-04-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A petx-20190419xdef14a.htm DEF 14A 829392
2 GRAPHIC petx-20190419xdef14ag001.jpg GRAPHIC 8822
3 GRAPHIC petx-20190419xdef14ag002.jpg GRAPHIC 5670
4 GRAPHIC petx-20190419xdef14ag003.jpg GRAPHIC 1053
5 GRAPHIC petx-20190419xdef14ag004.jpg GRAPHIC 843
6 GRAPHIC petx-20190419xdef14ag005.jpg GRAPHIC 6047
7 GRAPHIC petx-20190419xdef14ag006.jpg GRAPHIC 45334
8 GRAPHIC petx-20190419xdef14ag007.jpg GRAPHIC 87896
9 GRAPHIC petx-20190419xdef14ag008.jpg GRAPHIC 119530
  Complete submission text file 0001509190-19-000027.txt   1210694
Mailing Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211
Business Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 913.353.1000
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35952 | Film No.: 19758050
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1